Amgen Statistics

Total Valuation

Amgen has a market cap or net worth of GBP 128.77 billion. The enterprise value is 167.45 billion.

Market Cap	128.77B
Enterprise Value	167.45B

Important Dates

The last earnings date was Tuesday, February 4, 2025.

Earnings Date	Feb 4, 2025
Ex-Dividend Date	Feb 14, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.56%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	535.85M

Valuation Ratios

The trailing PE ratio is 39.41.

PE Ratio	39.41
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.78, with an EV/FCF ratio of 20.17.

EV / Earnings	51.26
EV / Sales	6.33
EV / EBITDA	13.78
EV / EBIT	21.88
EV / FCF	20.17

Financial Position

The company has a current ratio of 1.26, with a Debt / Equity ratio of 10.36.

Current Ratio	1.26
Quick Ratio	0.84
Debt / Equity	10.36
Debt / EBITDA	3.96
Debt / FCF	5.86
Interest Coverage	2.64

Financial Efficiency

Return on equity (ROE) is 67.55% and return on invested capital (ROIC) is 8.74%.

Return on Equity (ROE)	67.55%
Return on Assets (ROA)	6.40%
Return on Invested Capital (ROIC)	8.74%
Return on Capital Employed (ROCE)	14.08%
Revenue Per Employee	953,503
Profits Per Employee	116,677
Employee Count	28,000
Asset Turnover	0.35
Inventory Turnover	1.27

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +4.86% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+4.86%
50-Day Moving Average	276.72
200-Day Moving Average	305.86
Relative Strength Index (RSI)	70.24
Average Volume (20 Days)	22,180

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.42

Income Statement

In the last 12 months, Amgen had revenue of GBP 26.70 billion and earned 3.27 billion in profits. Earnings per share was 6.04.

Revenue	26.70B
Gross Profit	18.34B
Operating Income	7.73B
Pretax Income	3.68B
Net Income	3.27B
EBITDA	12.11B
EBIT	7.73B
Earnings Per Share (EPS)	6.04

Full Income Statement

Balance Sheet

The company has 9.56 billion in cash and 48.63 billion in debt, giving a net cash position of -39.06 billion.

Cash & Cash Equivalents	9.56B
Total Debt	48.63B
Net Cash	-39.06B
Net Cash Per Share	n/a
Equity (Book Value)	4.69B
Book Value Per Share	8.74
Working Capital	4.74B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 9.18 billion and capital expenditures -875.45 million, giving a free cash flow of 8.30 billion.

Operating Cash Flow	9.18B
Capital Expenditures	-875.45M
Free Cash Flow	8.30B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 68.71%, with operating and profit margins of 28.95% and 12.24%.

Gross Margin	68.71%
Operating Margin	28.95%
Pretax Margin	13.79%
Profit Margin	12.24%
EBITDA Margin	45.35%
EBIT Margin	28.95%
FCF Margin	31.10%

Dividends & Yields

This stock pays an annual dividend of 7.19, which amounts to a dividend yield of 2.42%.

Dividend Per Share	7.19
Dividend Yield	2.42%
Dividend Growth (YoY)	4.43%
Years of Dividend Growth	6
Payout Ratio	118.14%
Buyback Yield	-0.56%
Shareholder Yield	1.86%
Earnings Yield	2.54%
FCF Yield	6.45%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Amgen has an Altman Z-Score of 1.5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.5
Piotroski F-Score	n/a